1st Quarter - Report

PRIME THERAPEUTICS for PRIME THERAPEUTICS

Firm
Client
Income
—
Expenses
$240,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Prescription drug abuse

LobbyistCovered position, as disclosed
STACEY FAHRNER —

Contacted: Centers For Medicare and Medicaid Services (CMS); Office of Natl Drug Control Policy (NDCP); SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Proposed rule Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Program - retail pharmacy networks, preferred cost sharing, mail order fulfillment, non interference

LobbyistCovered position, as disclosed
STACEY FAHRNER —

Contacted: Office of Natl Drug Control Policy (NDCP); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.